Literature DB >> 24511047

Management of painful bone metastases: our experience according to scientific evidence on palliative radiotherapy.

Rossella Di Franco1, Sara Falivene, Vincenzo Ravo, Massimo Mammucari, Ennio Sarli, Stella Baffini, Giampaolo De Palma, Alfonsina Pepe, Marianna Traettino, Matteo Muto, Salvatore Cappabianca, Paolo Muto.   

Abstract

AIM: Our aim was to evaluate retrospectively the role of the radiotherapy in the multi-disciplinary management of pain due to bone metastases. PATIENTS AND METHODS: A total of 305 patients received radiotherapy with or without bisphosphonate and antalgic drugs. Tolerability and efficacy were evaluated using a Numerical Rating Scale, Pain Intensity Difference evaluation scale related to administration of the drug, a 5-point verbal scale of the patients' general impression.
RESULTS: We found differences in some patient subgroups: pain reduction was significantly more evident in patients treated with a single-fraction radiotherapy scheme. Overall, 68% of patients experienced an improvement in pain control using concomitant drugs during radiotherapy.
CONCLUSION: Our study underlines the role of radiotherapy in the management of metastatic bone pain. The use of rapid-onset opioids to prevent predictable pain is a crucial step in managing radiotherapy. An interdisciplinary approach is recommended.

Entities:  

Keywords:  Radiotherapy; bone metastases; fractionation; pain; rapid-onset opioids

Mesh:

Year:  2014        PMID: 24511047

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  P2X receptors: New players in cancer pain.

Authors:  Alessia Franceschini; Elena Adinolfi
Journal:  World J Biol Chem       Date:  2014-11-26

Review 2.  Role of Oxycodone Hydrochloride in Treating Radiotherapy-Related Pain.

Authors:  Yinxia Wang; Ligang Xing
Journal:  Pain Res Manag       Date:  2020-01-30       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.